X

Vous n'êtes pas connecté

Rubriques :

  - ZACKS.COM - All Stories - 11/Aug 22:55

Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of -70.00% and +4.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:10

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:10

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +17.14% and +190.70%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Fate Therapeutics (FATE) delivered earnings and revenue surprises of +17.14% and +190.70%, respectively, for the quarter ended June 2025. Do the...

Sorry! Image not available at this time

Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:15

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers...

Sorry! Image not available at this time

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:25

NeuroPace (NPCE) delivered earnings and revenue surprises of -8.33% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold...

Sorry! Image not available at this time

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates

zacks.com - 12/Aug 21:25

NeuroPace (NPCE) delivered earnings and revenue surprises of -8.33% and +0.75%, respectively, for the quarter ended June 2025. Do the numbers hold...

Les derniers communiqués